Literature DB >> 26256436

Response assessment for HCC patients treated with repeated TACE: The optimal time-point is still an open issue.

Wenjun Wang1, Yan Zhao1, Wei Bai1, Guohong Han2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26256436     DOI： 10.1016/j.jhep.2015.07.031

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

Review 1.  Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments.

Authors:  Xavier Adhoute; Guillaume Penaranda; Jean Luc Raoul; Patrice Le Treut; Emilie Bollon; Jean Hardwigsen; Paul Castellani; Hervé Perrier; Marc Bourlière
Journal:  World J Hepatol       Date:  2016-06-18

2.  Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study.

Authors:  Zhexuan Wang; Enxin Wang; Wei Bai; Dongdong Xia; Rong Ding; Jiaping Li; Qiuhe Wang; Lei Liu; Junhui Sun; Wei Mu; Hui Zhao; Xingnan Pan; Guoliang Shao; Xiaoli Zhu; Guowen Yin; Haibin Shi; Jianbing Wu; Zhengyu Lin; Shufa Yang; Jueshi Liu; Wenhui Wang; Xu Zhu; Yong Lv; Jing Li; Hui Chen; Wenjun Wang; Kai Li; Xulong Yuan; Tanlei Yu; Jie Yuan; Xiaomei Li; Jing Niu; Zhanxin Yin; Jielai Xia; Daiming Fan; Guohong Han
Journal:  Liver Cancer       Date:  2020-02-19       Impact factor: 11.740

3.  Transarterial chemoembolization combined with Jie-du granule preparation improves the survival outcomes of patients with unresectable hepatocellular carcinoma.

Authors:  Hetong Zhao; Xiaofeng Zhai; Zhe Chen; Xuying Wan; Lanyu Chen; Feng Shen; Changquan Ling
Journal:  Oncotarget       Date:  2017-07-11

4.  Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.

Authors:  Chunli Kong; Zhongwei Zhao; Weiyue Chen; Xiuling Lv; Gaofeng Shu; Miaoqing Ye; Jingjing Song; Xihui Ying; Qiaoyou Weng; Wei Weng; Shiji Fang; Minjiang Chen; Jianfei Tu; Jiansong Ji
Journal:  Eur Radiol       Date:  2021-04-16       Impact factor: 5.315

5.  Performance of initial LI-RADS 2018 treatment response in predicting survival of patients with hepatocellular carcinoma following TACE: a retrospective, single-center cohort study.

Authors:  Krzysztof Bartnik; Joanna Podgórska; Grzegorz Rosiak; Krzysztof Korzeniowski; Jakub Giziński; Michał Sajdek; Tadeusz Wróblewski; Krzysztof Zieniewicz; Paweł Nyckowski; Olgierd Rowiński
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-28       Impact factor: 4.553

6.  Radiologic Response Combined with Dermatologic Toxicities is the Most Robust Predictor of Survival Benefits in Patients with Inoperable Hepatocellular Carcinoma After Transarterial Chemoembolization Plus Sorafenib Therapy.

Authors:  Zhiqiu Ye; Zhizhen Deng; Suxiang Jiang; Tang Wang; Long Liu; Kuiming Jiang; Yingqiang Zhang
Journal:  Cardiovasc Intervent Radiol       Date:  2021-05-04       Impact factor: 2.740
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.